Literature DB >> 20409891

Hypertension prevention and control in Canada.

Norman R C Campbell1.   

Abstract

Canada has a similar prevalence of hypertension to the U.S., which is lower than the prevalence in many European countries. In contrast, Canada had similar treatment and control rates of hypertension to Europe, which are substantially lower than those of the U.S. To address this disparity, a national strategic plan was developed. While the strategy never received government resources for implementation, the Canadian hypertension community has successfully initiated certain aspects of the strategy. To date, programs include: a health professional education program, a national surveillance program, a public awareness program, and a program to reduce dietary sodium. The initiatives rely heavily on volunteers and on collaboration between many organizations and various government departments. Initially largely supported by corporate donations, the programs have received increased government resources over the last 2 years. The development of a funded leadership position beginning in 2006 (Canadian Institutes of Health Research Canada Chair in Hypertension Prevention and Control) has accelerated the initiatives. In the first 4 years of the health professional education program, there were large increases in the diagnosis and treatment of hypertension with corresponding reductions in cardiovascular disease. The Canadian programs could be adopted by countries with an organized and committed hypertension community.

Entities:  

Year:  2008        PMID: 20409891     DOI: 10.1016/j.jash.2007.10.001

Source DB:  PubMed          Journal:  J Am Soc Hypertens        ISSN: 1878-7436


  5 in total

1.  Canadian efforts to prevent and control hypertension.

Authors:  Norman R C Campbell; Guanmin Chen
Journal:  Can J Cardiol       Date:  2010 Aug-Sep       Impact factor: 5.223

2.  2009 Canadian Hypertension Education Program recommendations: an annual update.

Authors: 
Journal:  Can Fam Physician       Date:  2009-07       Impact factor: 3.275

Review 3.  Hypertension: are you and your patients up to date?

Authors:  Selina Omar Allu; Jocelyne Bellerive; Robin L Walker; Norm R C Campbell
Journal:  Can J Cardiol       Date:  2010-05       Impact factor: 5.223

4.  The prevalence of pre-hypertension and hypertension in an Iranian urban population.

Authors:  Ahmad Khosravi; Mohammad Hassan Emamian; Mohammad Shariati; Hassan Hashemi; Akbar Fotouhi
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-11-23

Review 5.  The determinants and scope of public health interventions to tackle the global problem of hypertension.

Authors:  Saurabh RamBihariLal Shrivastava; Prateek Saurabh Shrivastava; Jegadeesh Ramasamy
Journal:  Int J Prev Med       Date:  2014-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.